Abstract

The accidental discovery of polytetrafluoroethylene (PTFE) in 1938 by Roy J. Plunkett inaugurated the era of fluoropolymer chemistry, yielding materials of extraordinary chemical inertness and thermal stability. These properties, conferred by the exceptionally strong carbon-fluorine bond, propelled PTFE—commercialised as Teflon®—into applications ranging from nuclear weapons production to non-stick cookware. However, the processing aids required for PTFE manufacture, particularly perfluorooctanoic acid (PFOA, or C8), proved to be environmentally persistent, bioaccumulative, and toxic. This review traces the chemical history of fluorocarbons from Plunkett's serendipitous observation to the contemporary recognition of per- and polyfluoroalkyl substances (PFAS) as contaminants of global concern. Drawing on regulatory assessments from the U.S. Environmental Protection Agency, the National Academies of Sciences, Engineering, and Medicine, and the International Agency for Research on Cancer, we examine the toxicological profile of these compounds, their environmental fate, and the public health implications of decades of unregulated industrial release. The narrative illustrates a recurring pattern in industrial chemistry: the introduction of seemingly miraculous materials whose long-term consequences are only appreciated decades after widespread adoption.

1. Introduction

The history of organofluorine chemistry is punctuated by serendipity. On the morning of April 6, 1938, Dr. Roy J. Plunkett, a 27-year-old chemist working for DuPont at their Jackson Laboratory in New Jersey, was investigating novel chlorofluorocarbon refrigerants—compounds intended to replace the toxic and flammable gases that had caused numerous fatalities in domestic refrigeration. Plunkett's assistant, Jack Rebok, retrieved a cylinder of tetrafluoroethylene (TFE) that had been stored under pressure. When the valve was opened, no gas emerged. The cylinder, however, retained its full weight. What Plunkett discovered upon sawing open the cylinder was a white, waxy solid: TFE had spontaneously polymerised into polytetrafluoroethylene (PTFE). This material, initially an obstacle to his research, would become one of the most commercially significant accidental discoveries in chemical history. Yet the story of PTFE—and the broader family of per- and polyfluoroalkyl substances (PFAS) it spawned—illustrates a profound tension between technological utility and environmental stewardship.

2. The Carbon-Fluorine Bond: A Chemical Singularity

The exceptional properties of PTFE derive from a single chemical feature: the carbon-fluorine (C–F) bond. Among all single bonds carbon can form, the C–F bond is the strongest, with a bond dissociation energy of approximately 480 kJ mol⁻¹. This bond strength arises from fluorine's unique electronic configuration. As the most electronegative element, fluorine possesses a voracious appetite for electrons; its outer shell is one electron short of completion. The small atomic radius of fluorine allows its nucleus to approach carbon's electron cloud closely, resulting in significant electrostatic attraction that imparts partial ionic character to the bond. The C–F bond is also relatively short, approximately 1.4 Å, and strengthens as additional fluorine atoms are substituted onto the carbon centre.

In PTFE, every carbon is bonded to two fluorine atoms, creating a dense sheath of C–F bonds that effectively shields the carbon backbone from chemical attack. This molecular architecture renders PTFE inert to virtually all solvents, acids, and bases—a property that Plunkett himself demonstrated when his powder resisted dissolution in every solvent available in his laboratory. This chemical invulnerability, however, is a double-edged sword. The same bond strength that confers utility also confers environmental persistence. PTFE itself, as a high-molecular-weight polymer, is largely biologically inert; ingested particles are excreted without absorption. However, the processing aids required for its manufacture—notably perfluorooctanoic acid (PFOA) and, more recently, hexafluoropropylene oxide dimer acid (HFPO-DA, commercially known as GenX)—possess the same C–F bond strength but are small enough to enter biological systems.

3. From Laboratory Curiosity to Industrial Essentiality

3.1 Military Applications and the Manhattan Project

The strategic value of PTFE became apparent during the Second World War. DuPont, which had patented and trademarked the material as Teflon® in 1944, was already collaborating with the U.S. Army on the Manhattan Project. The production of enriched uranium for nuclear weapons required the handling of uranium hexafluoride (UF₆), a highly corrosive gas that degraded conventional gaskets, seals, and pipe linings. PTFE's chemical inertness made it the ideal material for containing UF₆. As Gordon Fee, manager of the Oak Ridge nuclear weapons plant, later remarked, "There was never a substitute considered, as far as I know." The material proved so effective that it was rapidly adopted for fuel tanks, aircraft engines, and explosives manufacturing.

3.2 The Challenge of Polymerisation

Despite its utility, PTFE presented formidable manufacturing challenges. The polymerisation of TFE is highly exothermic; if uncontrolled, the reaction can exceed 200 °C, at which point TFE decomposes explosively into carbon and tetrafluoromethane. An explosion at DuPont's Arlington, New Jersey, pilot plant in 1944 claimed the lives of two workers.

The solution to this safety problem came from an unlikely source: 3M, the manufacturer of Scotch tape. In 1951, DuPont acquired a fluorinated surfactant known as perfluorooctanoic acid (PFOA), which the company referred to as C8. PFOA possesses a hydrophobic perfluorinated tail, structurally analogous to PTFE, and a hydrophilic carboxylic acid head group. In aqueous solution, PFOA molecules self-assemble into micelles—spherical aggregates with the hydrophobic tails sequestered in the interior and the hydrophilic heads exposed to water. When TFE gas is injected into this solution, it partitions into the hydrophobic micelle interiors, becoming uniformly dispersed throughout the aqueous phase. Addition of an initiator triggers polymerisation within these nanoscale reaction vessels, with the heat of polymerisation effectively dissipated by the surrounding water. This micellar polymerisation technique enabled the safe, scalable production of PTFE as an aqueous dispersion suitable for coating applications.

4. The Commercialisation of a Miracle Material

With the conclusion of the Second World War, DuPont was permitted to commercialise Teflon. The material rapidly found applications across diverse industries. In 1954, French engineer Marc Gregoire, at his wife's suggestion, applied Teflon to cookware, creating the first non-stick frying pan. The product was a commercial sensation.

Teflon's utility extended far beyond the kitchen. Stain-resistant carpets and upholstery, waterproof breathable fabrics (Gore-Tex), medical implants, anti-corrosion coatings for the Statue of Liberty's steel framework, and even bullet coatings all exploited PTFE's unique properties. By the late 1990s, DuPont's Teflon business generated approximately one billion dollars in annual revenue. The term "Teflon" entered the cultural lexicon; when organised crime figure John Gotti repeatedly evaded conviction in the 1980s, he was dubbed the "Teflon Don"—a moniker acknowledging that, like the material, charges would not stick.

5. The Hidden Cost: PFOA Toxicity and Environmental Contamination

5.1 Early Evidence of Toxicity

While PTFE itself was recognised as biologically inert, the processing aid PFOA was a different matter entirely. DuPont's internal toxicological studies, conducted as early as 1961, revealed that PFOA caused abnormal liver growth in rats at doses as low as 1.5 mg kg⁻¹, with lethality at 570 mg kg⁻¹. By 1962, repeated studies confirmed that high doses caused injury to the stomach, intestine, brain, lungs, and pancreas. Subsequent investigations in dogs (1965) and primates documented similar toxic effects across multiple organ systems.

The mechanism of PFOA toxicity is intimately related to its molecular structure. PFOA structurally resembles natural fatty acids, with a perfluorinated carbon chain terminating in a carboxylic acid group. This structural mimicry allows PFOA to bind to serum proteins responsible for fatty acid transport, facilitating its distribution throughout the body. The C–F bonds render PFOA completely resistant to metabolic degradation; consequently, it accumulates in biological systems with a human serum elimination half-life estimated at 2–4 years.

5.2 The Parkersburg Contamination

DuPont's Washington Works facility, located near Parkersburg, West Virginia, was the first commercial PTFE plant. For decades, the company disposed of PFOA-containing waste in unlined landfills and discharged effluents into the Ohio River. By the 1980s, DuPont's own testing revealed that PFOA had contaminated the public water supply. In 1984, company officials considered replacing PFOA with a safer alternative but concluded that none was "economically attractive".

The contamination came to public attention through the efforts of Earl Tennant, a cattle farmer whose animals exhibited wasting, tumours, and blackened teeth after drinking from a creek fed by a DuPont landfill drainage pipe. Tennant's attorney, Rob Bilott, reviewed more than 60,000 pages of DuPont documents, uncovering evidence that the company had known of PFOA's toxicity for decades. In 2001, Bilott filed a class-action lawsuit on behalf of approximately 70,000 Parkersburg residents exposed to PFOA through drinking water.

5.3 The C8 Science Panel

As part of a settlement agreement, DuPont funded an independent epidemiological study—the C8 Health Project—which collected blood samples and medical histories from the affected community. In 2012, the C8 Science Panel published its findings, confirming a probable link between PFOA exposure and six human diseases: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension, and hypercholesterolaemia. These findings were based on a population with average serum PFOA levels of 28 parts per billion (ppb)—substantially higher than the U.S. general population average of approximately 5 ppb at that time.

The International Agency for Research on Cancer (IARC) has subsequently classified PFOA as carcinogenic to humans (Group 1), based on sufficient evidence for cancer in experimental animals and strong mechanistic evidence in exposed humans. The U.S. Environmental Protection Agency (EPA) has determined that PFOA and PFOS are "likely to be carcinogenic to humans," citing evidence of kidney and testicular cancer in humans, as well as Leydig cell tumours, pancreatic acinar cell tumours, and hepatocellular adenomas in rats.

6. PFAS: A Family of Forever Chemicals

PFOA is but one member of a vast chemical family. Per- and polyfluoroalkyl substances (PFAS) encompass more than 14,000 synthetic compounds characterised by carbon-fluorine bonds. The generic term covers a diverse range of structures: long-chain and short-chain, linear and branched, polymers and acids.

6.1 Classification and Properties

PFAS can be broadly divided into two categories. Fluoropolymers, such as PTFE, consist of long repeating chains of carbon-fluorine bonds with molecular weights exceeding tens of thousands of daltons. These molecules are too large to be absorbed through the gastrointestinal tract and are generally considered biologically inert. However, their manufacture requires processing aids—low-molecular-weight perfluoroalkyl acids such as PFOA and PFOS (perfluorooctane sulfonic acid) that are 5–10 carbons in length. These small molecules can enter the bloodstream, bind to serum proteins, and accumulate in tissues.

6.2 Environmental Persistence and Global Distribution

The C–F bond's strength renders PFAS extraordinarily persistent in the environment. Unlike many organic contaminants, PFAS do not undergo hydrolysis, photolysis, or microbial degradation under environmental conditions. They have been detected in every continent, including Antarctica, and in virtually every living organism sampled, from polar bears to fish to humans. In 2000, researchers analysing blood samples from thousands of Americans found detectable PFOA in 100% of samples.

The primary route of human exposure is ingestion of contaminated drinking water and food. PFAS-containing products—including non-stick cookware, waterproof clothing, stain-resistant furniture, and food packaging—can release PFAS into the environment during manufacture, use, and disposal. Firefighting foams, particularly those used at military bases and airports, represent a major point source of contamination.

6.3 The GenX Alternative

In response to regulatory pressure to phase out PFOA, DuPont (and its spin-off Chemours) introduced GenX, a shorter-chain perfluoroether carboxylic acid (HFPO-DA), as a replacement. With a chain of six carbons interrupted by an oxygen atom, GenX was expected to be more readily degradable and less bioaccumulative. Chemours initially asserted that drinking water concentrations up to 70 ppb of GenX would be safe.

However, subsequent toxicological studies have raised concerns. Animal studies have demonstrated that GenX causes the same three tumour types in rats—liver, testicular, and pancreatic—as PFOA. The EPA's final human health toxicity assessment for HFPO-DA (2021) and subsequent drinking water regulations have set a maximum contaminant level of 10 parts per trillion (ppt) for GenX—a dramatic reduction from Chemours's initial safety claim. Moreover, GenX's shorter chain and greater mobility may enable it to contaminate larger areas. As one researcher observed, "This is Whac-A-Mole. We get to the point we're addressing one and the new one pops up".

7. Health Effects: The Current Scientific Consensus

The most comprehensive assessment of PFAS health effects to date was published in 2022 by the National Academies of Sciences, Engineering, and Medicine (NASEM). The report, Guidance on PFAS Exposure, Testing, and Clinical Follow-Up, reviewed the epidemiological evidence for seven perfluoroalkyl acids (PFOA, PFOS, PFHxS, PFNA, PFDA, PFUnDA, and MeFOSAA).

7.1 Established Health Effects

The NASEM committee found sufficient evidence of association between PFAS exposure and four health outcomes:

  1. Decreased antibody response to vaccines, indicating immunosuppression. The National Toxicology Program has concluded that PFOA and PFOS are "presumed to be an immune hazard to humans".
  2. Dyslipidemia (abnormally high cholesterol levels).
  3. Decreased infant and fetal growth, including reduced birth weight.
  4. Increased risk of kidney cancer.

7.2 Dose-Response and Risk Stratification

The NASEM report proposed a risk stratification framework based on the sum of serum concentrations of the seven monitored PFAS:

  • Below 2 ppb: No anticipated harm.
  • 2–20 ppb: Potential for adverse health effects, with recommendations for clinical surveillance.
  • Above 20 ppb: Elevated risk, warranting additional screening for PFAS-associated diseases.

It is important to note that the exact mechanisms of PFAS toxicity remain incompletely understood. Proposed pathways include activation of peroxisome proliferator-activated receptor alpha (PPARα), disruption of thyroid hormone homeostasis, and interference with lipid metabolism. However, interspecies differences in PPARα sensitivity—rodents are approximately five times more responsive than humans—complicate extrapolation from animal studies.

8. Regulatory Response

8.1 U.S. Environmental Protection Agency

On April 10, 2024, the EPA finalised the first-ever national primary drinking water regulation for six PFAS. The regulation established legally enforceable maximum contaminant levels (MCLs):

Compound MCL (parts per trillion)
PFOA 4 ppt
PFOS 4 ppt
PFHxS 10 ppt
PFNA 10 ppt
HFPO-DA (GenX) 10 ppt
Mixture of PFHxS, PFNA, HFPO-DA, and PFBS Hazard index of 1

For context, the EPA's MCL for lead in drinking water is 10,000 ppt; for cyanide, it is 200,000 ppt. The stringency of the PFAS limits reflects the extraordinary toxicity and persistence of these compounds.

8.2 International Classifications

IARC has classified PFOA as carcinogenic to humans (Group 1). PFOS has been classified as possibly carcinogenic to humans (Group 2B), based on limited evidence for cancer in experimental animals and strong mechanistic evidence in exposed humans.

8.3 Industry Response and Regulatory Challenges

DuPont and its spinoff Chemours have denied wrongdoing throughout. In 2017, DuPont agreed to pay over $600 million to victims of C8 exposure—a sum representing less than 1% of the company's annual sales at the time.

The regulatory landscape remains contentious. Critics of the EPA's 2024 rule have argued that the agency relied on animal data that poorly predict human responses, that epidemiological evidence for certain cancer endpoints is equivocal, and that the projected health benefits may not justify the substantial compliance costs. These criticisms underscore the scientific and policy challenges inherent in regulating chemicals whose effects manifest over decades.

9. Conclusion: Lessons for Materials Chemistry

The history of fluorocarbons offers sobering lessons for the field of materials chemistry. Plunkett's serendipitous discovery exemplified the transformative potential of basic research; PTFE's unique properties enabled technologies—from nuclear weapons to medical implants—that would otherwise have been impossible. Yet the processing aids required for its manufacture, selected for their surfactant properties rather than their biological safety, have become contaminants of global concern.

The PFAS story illustrates a recurring pattern in industrial chemistry. Leaded gasoline, chlorofluorocarbons, and asbestos each followed a similar trajectory: initial enthusiasm for a novel material, widespread adoption, belated recognition of toxicity, and protracted litigation and regulation. In each case, the interval between introduction and regulation was measured in decades—a timescale during which exposure accumulated across entire populations.

The challenge for contemporary materials chemistry is to anticipate these long-term consequences before they manifest. This requires: (1) rigorous toxicological screening of processing aids and byproducts, not merely final products; (2) assessment of environmental persistence and bioaccumulation potential; (3) transparent sharing of industrial health data; and (4) regulatory frameworks that can respond to emerging evidence without waiting for incontrovertible proof of harm.

As the NASEM report concluded, "We need to continue to identify communities with elevated PFAS exposure, learn more about specific health impacts, make testing available to patients, and give clinicians more strategies for counseling patients and providing preventive medical care". These recommendations apply equally to the scientific community, which must continue to elucidate the mechanisms of PFAS toxicity; to industry, which must develop truly safer alternatives; and to regulators, who must balance technological necessity against public health protection.

The carbon-fluorine bond remains one of chemistry's most remarkable achievements—a testament to the power of molecular design. But its very strength, the source of its utility, is also the source of its danger. The challenge of the coming decades will be to harness this bond's remarkable properties while ensuring that its benefits are not purchased at the expense of environmental and human health.

References

  1. National Academies of Sciences, Engineering, and Medicine. (2022). Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press.
  2. U.S. Environmental Protection Agency. (2024). Per- and Polyfluoroalkyl Substances (PFAS) National Primary Drinking Water Regulation. Federal Register, 89(90), 39144-39250.
  3. International Agency for Research on Cancer. (2023). IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 135: Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS). Lyon: IARC.
  4. Paustenbach, D., et al. (2025). United States Environmental Protection Agency's Perfluorooctanoic Acid, Perfluorooctane Sulfonic Acid, and Related Per- and Polyfluoroalkyl Substances 2024 Drinking Water Maximum Contaminant Level: Part 2 - Fifteen Misconceptions About the Health Hazards. Critical Reviews in Toxicology. DOI: 10.1080/10408444.2024.2446453.
  5. Kwiatkowski, C.F., et al. (2020). Scientific Basis for Managing PFAS as a Chemical Class. Environmental Science & Technology Letters, 7(8), 532-543.
  6. U.S. Environmental Protection Agency. (2021). Human Health Toxicity Assessment for Hexafluoropropylene Oxide Dimer Acid and Its Ammonium Salt (GenX Chemicals). Washington, DC: EPA.
  7. Plunkett, R.J. (1941). Tetrafluoroethylene Polymers. U.S. Patent 2,230,654.
  8. C8 Science Panel. (2012). Probable Link Reports.
  9. Agency for Toxic Substances and Disease Registry. (2021). Toxicological Profile for Perfluoroalkyls. Atlanta: U.S. Department of Health and Human Services.
  10. National Toxicology Program. (2016). Immunotoxicity Associated with Exposure to Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS). Research Triangle Park: NTP.